30.07.2010 • NewsQ2 2010Wacker

Wacker Ends Q2 2010 with New Sales Record

Wacker Chemie ended Q2 2010 with a new sales record, primarily thanks to much higher sales volumes. Q2 2010 sales climbed 30% to €1,202.0 million (Q2 2009: €925.5 million). Growth was additionally driven by the stronger US dollar. In contrast, lower prices slowed the sales increase to some extent.

Wacker also posted clear earnings gains compared to both a year ago and Q1 2010. Earnings before interest, taxes, depreciation and amortization (Ebitda) in Q2 climbed to €308.6 million (Q2 2009: €170.1 million) up over 81% on the prior year, Ebitda rose at more than double the rate of sales.

Company

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation